|
 Roche is one of the main suppliers of diagnostic tests to Britain's
National Health Service (NHS) Test and Trace programme, which only
days ago was hit by a technical glitch that delayed the reporting of
15,000 positive results.
Roche said the delay in dispatching some of its diagnostic products
to the NHS was caused by unforeseen problems that arose during a
switch from an old warehouse to a new UK distribution centre in
September.
"We deeply regret that there has been a delay in the dispatch of
some products and apologise to any of our customers who have been
impacted," Roche said in a statement.
"We are prioritising the dispatch of COVID-19 PCR and antibody tests
and doing everything we can to ensure there is no impact on the
supply of these to the NHS," the company added, without specifying
whether other products were affected.
Allan Wilson, president of Britain's Institute of Biomedical
Science, said Roche was a major supplier of materials such as
reagents needed for routine blood tests, coagulation tests and in
cancer diagnostics, as well as COVID-related materials.
"So it's fair to say that laboratories are already running into
supply problems," Wilson said during an interview on BBC Radio 4.
"We're being very innovative in what we do, and we're moving stuff
around between laboratories, within the NHS, to make sure that all
critical tests are fulfilled."
Wilson said materials would be rationed when appropriate and the NHS
was working closely with Roche to try and plug any gaps in the
testing pathway.
Roche said staff at the new facility were working day and night to
resolve the issue as soon as possible, and that extra staff had been
recruited to help.
[to top of second column] |
DAYS OR WEEKS
The timing of Roche's problems could hardly be worse for Britain,
which has seen a surge in new coronavirus infections in September
and the testing system struggling to meet demand.
Wilson said a significant drop in Roche's capacity could potentially have a
major impact on NHS Test and Trace.
"The key to this, we're not sure the duration of this, we're hearing days or
weeks. If it's days, it will probably have minimal impact, but if it's weeks,
then yes, that could have a considerable impact on our ability to deliver tests
across the whole gambit of diagnostic tests in the UK," he said.
Trade minister Liz Truss said the problem did not appear to be causing delays in
the Test and Trace programme at this point.
"There's no evidence that those tests have been delayed," Truss told Sky News.
However, British media reported the problem was already causing disruption, with
hospital managers unsure whether expected deliveries of swabs and reagents would
materialise.
The BBC quoted Tom Lewis, lead clinician for pathology at North Devon District
Hospital in southwest England, as saying the hospital had already sent out
instructions to halt all non-urgent blood tests in the community.
Lewis said the hospital would run out of swabs in three to four days if the
non-urgent tests were not rationed.
(Additional reporting by Andy Bruce and Sarah Young in London and Aakriti Bhalla
in Bengaluru; editing by Guy Faulconbridge and Mark Potter)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |
